Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01638078
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01638078
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT01638078. Randomized; quadruple masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Thalidomide fOr the Prevention of Restenosis After Coronary ArtERy Stent Implantation
- Acronym
- TOP RACER
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Thalidomide
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01638078- Content hash
7529a1b1dd3762292241a66026031045646e7f2bc56c16c10a2c2cd0d175bfbb